Active Ingredient: MIDAZOLAM
Proprietary Name: MIDAZOLAM IN 0.8% SODIUM CHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 100MG/100ML (1MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215868
Product Number: 002
Approval Date: Jul 20, 2022
Applicant Holder Full Name: EXELA PHARMA SCIENCES LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
